Hester Biosciences Ltd (HESTERBIO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 324228,
    "name": "Hester Bios",
    "stock_name": "Hester Bios",
    "full_name": "Hester Biosciences Ltd",
    "name_url": "stocks-analysis/hester-bios",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,049.30",
    "chg": -4.8,
    "chgp": "-0.23%",
    "dir": -1,
    "prev_price": "2,054.10",
    "mcapval": "1,763.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524669,
    "symbol": "HESTERBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE782E01017",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "10.29 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/hester-bios-324228-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4002053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HesterBioscienc_technicaldot_4002053.png",
        "date": "2026-05-21 08:00:56",
        "description": "Hester Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a recent 2.40% gain in the stock price to ₹1,839.85, the company’s overall technical outlook remains mixed, with divergent signals from MACD, RSI, moving averages, and other momentum oscillators."
      },
      {
        "title": "Are Hester Biosciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-hester-biosciences-ltd-latest-results-good-or-bad-4001466",
        "imagepath": "",
        "date": "2026-05-20 19:20:25",
        "description": "Hester Biosciences Ltd's latest financial results for Q4 FY26 indicate a notable operational turnaround compared to the previous year. The company reported a consolidated net profit of ₹15.98 crores, reflecting a significant year-on-year growth of 1,138.76%, a stark contrast to the near-zero profitability recorded in the same quarter last year. Additionally, revenue reached ₹100.11 crores, marking a year-on-year increase of 22.19% and surpassing previous quarterly records.\n\nThe operating margin for this quarter stood at 34.29%, which is the highest in the company's history, showcasing substantial margin expansion driven by improved operational efficiencies and cost management. This margin represents a significant improvement from the prior year's figures, indicating a strong recovery in profitability.\n\nSequentially, the results also demonstrate positive momentum, with net profit increasing by 82.21% from ₹8..."
      },
      {
        "title": "Hester Biosciences Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3997816",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HesterBioscienc_technicaldot_3997816.png",
        "date": "2026-05-19 08:01:47",
        "description": "Hester Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend as of mid-May 2026. Despite a recent downgrade in technical trend sentiment, the stock’s mixed signals across key indicators such as MACD, RSI, Bollinger Bands, and moving averages suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Hester Biosciences Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Comparisons",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-valuation-shifts-signal-heightened-price-risk-amid-sector-comparisons-3963490",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_valuationdot_3963490.png",
        "date": "2026-04-27 08:00:18",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift markedly, moving from expensive to very expensive territory. Despite a modest day gain of 1.27%, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios raise questions about its price attractiveness relative to peers and historical benchmarks."
      },
      {
        "title": "Hester Biosciences Gains 0.35%: 3 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-gains-035-3-key-factors-driving-the-weeks-mixed-momentum-3962957",
        "imagepath": "",
        "date": "2026-04-26 09:00:04",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Apr:</strong> Stock opens at Rs.1,477.25, down 1.04% amid weak market sentiment</p>\n                    <p><strong>21 Apr:</strong> Technical momentum shifts amid bearish signals; valuation shifts to “expensive” rating</p>\n                    <p><strong>22 Apr:</strong> Technical momentum shows mild improvement but remains cautious</p>\n                    <p><strong>24 Apr:</strong> Stock closes the week at Rs.1,498.00, up 1.27% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,492.80</div></div>\n                    <div class=\"stat-item\"><..."
      },
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-bearish-signals-3954920",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_technicaldot_3954920.png",
        "date": "2026-04-21 08:01:42",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from mildly bearish to a more pronounced bearish stance. Despite some mildly bullish weekly indicators, the overall technical landscape suggests caution for investors as key momentum and trend indicators signal weakening price strength."
      },
      {
        "title": "Hester Biosciences Ltd: Valuation Shifts Signal Price Attractiveness Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-valuation-shifts-signal-price-attractiveness-amid-sector-challenges-3954800",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_valuationdot_3954800.png",
        "date": "2026-04-21 08:00:21",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change reflects evolving market perceptions of the stock’s price attractiveness amid fluctuating financial metrics and sector comparisons."
      },
      {
        "title": "Hester Biosciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-is-rated-sell-3942457",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HesterBioscienc_mojoScore_3942457.png",
        "date": "2026-04-11 10:10:25",
        "description": "Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 15,
    "sid": "324228",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/hester-biosciences-324228"
  },
  "announcements": [
    {
      "caption": "Announcement Under Regulation 30 Of Listing Regulations - Disclosure On Amendments In Loan Agreement Of Hester Africa",
      "datetime": "20-May-2026",
      "details": "Announcement under Regulation 30 of Listing Regulation - Amendments in Loan agreement of Hester Africa",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Submission Of The Reclassification Application Under Regulation 31A Of Listing Regulations",
      "datetime": "20-May-2026",
      "details": "Intimation of Submission of reclassification application with the stock exchanges under Regulations 31A of Listing Regulations",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "18-May-2026",
      "details": "Annual Secretarial Compliance Report for the year ended 31 March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has declared <strong>70%</strong> dividend, ex-date: 06 Aug 25",
          "dt": "2025-08-06",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 27 Sep 12",
          "dt": "2012-09-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>2:5</strong> rights issue, ex-date: 29 May 06",
          "dt": "2006-05-29",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-21 08:00:56

Hester Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a recent 2.40% gain in the stock price to ₹1,839.85, the company’s overall technical outlook remains mixed, with divergent signals from MACD, RSI, moving averages, and other momentum oscillators.

Are Hester Biosciences Ltd latest results good or bad?

2026-05-20 19:20:25

Hester Biosciences Ltd's latest financial results for Q4 FY26 indicate a notable operational turnaround compared to the previous year. The company reported a consolidated net profit of ₹15.98 crores, reflecting a significant year-on-year growth of 1,138.76%, a stark contrast to the near-zero profitability recorded in the same quarter last year. Additionally, revenue reached ₹100.11 crores, marking a year-on-year increase of 22.19% and surpassing previous quarterly records. The operating margin for this quarter stood at 34.29%, which is the highest in the company's history, showcasing substantial margin expansion driven by improved operational efficiencies and cost management. This margin represents a significant improvement from the prior year's figures, indicating a strong recovery in profitability. Sequentially, the results also demonstrate positive momentum, with net profit increasing by 82.21% from ₹8...

Hester Biosciences Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-05-19 08:01:47

Hester Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish trend as of mid-May 2026. Despite a recent downgrade in technical trend sentiment, the stock’s mixed signals across key indicators such as MACD, RSI, Bollinger Bands, and moving averages suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Hester Biosciences Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Comparisons

2026-04-27 08:00:18

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift markedly, moving from expensive to very expensive territory. Despite a modest day gain of 1.27%, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios raise questions about its price attractiveness relative to peers and historical benchmarks.

Hester Biosciences Gains 0.35%: 3 Key Factors Driving the Week’s Mixed Momentum

2026-04-26 09:00:04

Key Events This Week 20 Apr: Stock opens at Rs.1,477.25, down 1.04% amid weak market sentiment 21 Apr: Technical momentum shifts amid bearish signals; valuation shifts to “expensive” rating 22 Apr: Technical momentum shows mild improvement but remains cautious 24 Apr: Stock closes the week at Rs.1,498.00, up 1.27% on the day Week OpenRs.1,492.80 <...

Hester Biosciences Ltd Technical Momentum Shifts Amid Bearish Signals

2026-04-21 08:01:42

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from mildly bearish to a more pronounced bearish stance. Despite some mildly bullish weekly indicators, the overall technical landscape suggests caution for investors as key momentum and trend indicators signal weakening price strength.

Hester Biosciences Ltd: Valuation Shifts Signal Price Attractiveness Amid Sector Challenges

2026-04-21 08:00:21

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change reflects evolving market perceptions of the stock’s price attractiveness amid fluctuating financial metrics and sector comparisons.

Hester Biosciences Ltd is Rated Sell

2026-04-11 10:10:25

Hester Biosciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

View All News